AJP - Endo Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 280: E199-E202, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granneman, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granneman, J. G.
Vol. 280, Issue 2, E199-E202, February 2001

INVITED REVIEW
The putative beta 4-adrenergic receptor is a novel state of the beta 1-adrenergic receptor

James G. Granneman

Cellular and Clinical Neurobiology Program, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan 48201

The atypical beta 3-adrenergic receptor (AR) agonist CGP-12177 has been used to define a novel atypical beta -AR subtype, the putative beta 4-AR. Recent evaluation of recombinant beta -AR subtypes and beta -AR-deficient mice, however, has established the identity of the pharmacological beta 4-AR as a novel state of the beta 1-AR protein. The ability of aryloxypropanolamine ligands like CGP-12177 to independently interact with agonist and antagonist states of the beta 1-AR has important implications regarding receptor classification and the potential development of tissue-specific beta -AR agonists.

LY-362884; propranolol; catecholamines; phenethanolamines; thermogenesis; lipolysis receptor sites and receptor proteins


This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. M. Mutlu and P. Factor
Alveolar Epithelial 2-Adrenergic Receptors
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 127 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. G. Baker
Site of Action of {beta}-Ligands at the Human {beta}1-Adrenoceptor
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1163 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Leblais, F. Pourageaud, M. D. Ivorra, C. Guibert, R. Marthan, and B. Muller
Role of {alpha}-Adrenergic Receptors in the Effect of the {beta}-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 137 - 145.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
S. L. Kirstein and P. A. Insel
Autonomic Nervous System Pharmacogenomics: A Progress Report
Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. I. Gobran and S. A. Rooney
Pulmonary surfactant secretion in briefly cultured mouse type II cells
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L331 - L336.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev, January 1, 2004; 84(1): 277 - 359.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Granneman, M. Burnazi, Z. Zhu, and L. A. Schwamb
White adipose tissue contributes to UCP1-independent thermogenesis
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1230 - E1236.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Jost, M. Fasshauer, C. R. Kahn, M. Benito, M. Meyer, V. Ott, B. B. Lowell, H. H. Klein, and J. Klein
Atypical beta -adrenergic effects on insulin signaling and action in beta 3-adrenoceptor-deficient brown adipocytes
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E146 - E153.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online